MSP Recovery (MSPR) investor relations material

Executive summary

• Report covers the quarter ended September 30, 2025, with a focus on healthcare claims recovery and data analytics operations.

• The company continues to face significant liquidity challenges and has incurred substantial net losses since inception.

• A 1-for-7 reverse stock split was effected on September 1, 2025, to maintain Nasdaq listing compliance.

• The company is at risk of delisting from Nasdaq due to non-compliance with minimum stockholders' equity requirements.

Financial highlights

• Total revenue for Q3 2025 was $0.2 million, down 95% year-over-year; nine-month revenue was $1.6 million, down 84%.

• Net loss for Q3 2025 was $245.5 million, a 29% increase from Q3 2024; nine-month net loss was $723.3 million, up 25%.

• Operating loss for Q3 2025 was $123.8 million; for the nine months, $375.5 million.

• Interest expense rose to $130.5 million in Q3 2025 and $374.0 million for the nine months, mainly due to increased debt obligations.

• Cash at September 30, 2025 was $1.8 million, down from $12.3 million at year-end 2024.

• Accumulated deficit reached $878.6 million as of September 30, 2025.

Outlook and guidance

• Management has concluded that plans are insufficient to alleviate substantial doubt about the company's ability to continue as a going concern.

• The Yorkville SEPA is currently the sole source of liquidity; if unavailable, insolvency or bankruptcy may be required.

• No formal financial guidance provided; future revenue depends on successful claims recovery and additional financing.